Literature DB >> 30607809

EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

Mihir Gandhi1,2,3, Marcus Ang4,5, Kelvin Teo6, Chee Wai Wong6, Yvonne Chung-Hsi Wei6, Rachel Lee-Yin Tan7, Mathieu F Janssen8, Nan Luo7.   

Abstract

BACKGROUND: It is not clear whether 5-level EQ-5D (EQ-5D-5L) utilities based on recently developed value sets are more responsive than 3-level EQ-5D (EQ-5D-3L) utilities.
OBJECTIVES: The study aims were to compare (1) the responsiveness of EQ-5D-5L and EQ-5D-3L utilities and (2) the responsiveness of these utilities with the Short Form-6 Dimension (SF-6D) and Health Utilities Index Mark 3 (HUI3) utilities to the treatment benefit of cataract surgery.
METHODS: A total of 148 patients were interviewed before and after their cataract surgery using EQ-5D-3L, EQ-5D-5L, SF-6D, and HUI3. Responsiveness was assessed for all measures using the mean change (post-treatment-pre-treatment), standardized effect size (SES), standardized response mean (SRM), and F-statistic.
RESULTS: Using the Singapore value sets, mean change for EQ-5D-3L and EQ-5D-5L utilities was 0.016 and 0.028, SES was 0.097 and 0.199; SRM was 0.091 and 0.196; and F-statistic was 1.2 and 5.7, respectively. Similar trends were observed using the UK/England EQ-5D value sets, although the magnitude was slightly smaller. The mean change, SES, SRM and F-statistics for SF-6D (UK value set) were 0.020, 0.234, 0.249, and 9.2, respectively. The values of mean change, SES, SRM and F-statistics for HUI3 (Canada value set) were 0.080, 0.472, 0.474, and 33.3, respectively.
CONCLUSIONS: The EQ-5D-5L utilities tend to be more responsive than the EQ-5D-3L utilities to treatment benefits of cataract surgery. The HUI3 utilities are more responsive than both the EQ-5D-5L and SF-6D, and SF-6D utilities may be slightly more responsive than the EQ-5D-5L for assessing patients undergoing cataract surgery.

Entities:  

Year:  2019        PMID: 30607809     DOI: 10.1007/s40271-018-00354-7

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  44 in total

Review 1.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

2.  Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.

Authors:  Ben van Hout; M F Janssen; You-Shan Feng; Thomas Kohlmann; Jan Busschbach; Dominik Golicki; Andrew Lloyd; Luciana Scalone; Paul Kind; A Simon Pickard
Journal:  Value Health       Date:  2012-05-24       Impact factor: 5.725

3.  The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore.

Authors:  Pei Wang; Nan Luo; E S Tai; Julian Thumboo
Journal:  Value Health Reg Issues       Date:  2016-01-19

4.  Utility of EQ-5D to assess patients undergoing cataract surgery.

Authors:  Marcus Ang; Eva Fenwick; Tien Yin Wong; Ecosse Lamoureux; Nan Luo
Journal:  Optom Vis Sci       Date:  2013-08       Impact factor: 1.973

5.  Measuring changes in health over time using the EQ-5D 3L and 5L: a head-to-head comparison of measurement properties and sensitivity to change in a German inpatient rehabilitation sample.

Authors:  Ines Buchholz; Kirsten Thielker; You-Shan Feng; Peter Kupatz; Thomas Kohlmann
Journal:  Qual Life Res       Date:  2014-10-30       Impact factor: 4.147

6.  The VF-14. An index of functional impairment in patients with cataract.

Authors:  E P Steinberg; J M Tielsch; O D Schein; J C Javitt; P Sharkey; S D Cassard; M W Legro; M Diener-West; E B Bass; A M Damiano
Journal:  Arch Ophthalmol       Date:  1994-05

7.  Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.

Authors:  Dominik Golicki; Maciej Niewada; Anna Karlińska; Julia Buczek; Adam Kobayashi; M F Janssen; A Simon Pickard
Journal:  Qual Life Res       Date:  2014-11-26       Impact factor: 4.147

8.  Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?

Authors:  Yan Feng; Nancy Devlin; Mike Herdman
Journal:  Health Qual Life Outcomes       Date:  2015-10-21       Impact factor: 3.186

9.  EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes.

Authors:  Mark Oppe; Kim Rand-Hendriksen; Koonal Shah; Juan M Ramos-Goñi; Nan Luo
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981

10.  Valuing health-related quality of life: An EQ-5D-5L value set for England.

Authors:  Nancy J Devlin; Koonal K Shah; Yan Feng; Brendan Mulhern; Ben van Hout
Journal:  Health Econ       Date:  2017-08-22       Impact factor: 3.046

View more
  12 in total

1.  A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.

Authors:  Mihir Gandhi; Marcus Ang; Kelvin Teo; Chee Wai Wong; Yvonne Chung-Hsi Wei; Rachel Lee-Yin Tan; Mathieu F Janssen; Nan Luo
Journal:  Eur J Health Econ       Date:  2020-01-04

2.  Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China.

Authors:  Yanhui Si; Shunping Li; Yanjiao Xu; Gang Chen
Journal:  Qual Life Res       Date:  2021-12-02       Impact factor: 4.147

3.  Comparison of EQ-5D-3L and 5L versions following operative fixation of closed ankle fractures.

Authors:  Andrew Garratt; Knut Stavem
Journal:  Qual Life Res       Date:  2022-02-19       Impact factor: 3.440

Review 4.  Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review.

Authors:  Xinyu Qian; Rachel Lee-Yin Tan; Ling-Hsiang Chuang; Nan Luo
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

5.  Psychometric properties of the EQ-5D-5L: a systematic review of the literature.

Authors:  You-Shan Feng; Thomas Kohlmann; Mathieu F Janssen; Ines Buchholz
Journal:  Qual Life Res       Date:  2020-12-07       Impact factor: 4.147

6.  Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.

Authors:  A M Garratt; H Furunes; C Hellum; T Solberg; J I Brox; K Storheim; L G Johnsen
Journal:  Health Qual Life Outcomes       Date:  2021-05-28       Impact factor: 3.186

7.  Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.

Authors:  Katie Breheny; William Hollingworth; Rebecca Kandiyali; Padraig Dixon; Abi Loose; Pippa Craggs; Mariusz Grzeda; John Sparrow
Journal:  Qual Life Res       Date:  2020-02-20       Impact factor: 4.147

8.  Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.

Authors:  Arjun Bhadhuri; Paul Kind; Paola Salari; Katharina Tabea Jungo; Benoît Boland; Stephen Byrne; Stefanie Hossmann; Olivia Dalleur; Wilma Knol; Elisavet Moutzouri; Denis O'Mahony; Kevin D Murphy; Linda Wisselink; Nicolas Rodondi; Matthias Schwenkglenks
Journal:  Health Qual Life Outcomes       Date:  2020-09-29       Impact factor: 3.186

9.  Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study.

Authors:  Xin Hu; Mingxia Jing; Mei Zhang; Ping Yang; Xiaolong Yan
Journal:  Health Qual Life Outcomes       Date:  2020-10-02       Impact factor: 3.186

10.  Validity of the EQ-5D-5L questionnaire among the general population of Poland.

Authors:  Katarzyna Młyńczak; Dominik Golicki
Journal:  Qual Life Res       Date:  2020-10-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.